MedTrace Logo

An Institutional Pilot Study to Investigate Physical Activity Patterns in Boys With Hemophilia

NCT02199717 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 66

Last updated 2016-12-14

Study results available
· View outcomes & findings →

Summary

This pilot project was developed to investigate subjective and objective data related to the patterns of physical activity participation among hemophilia patients (FVIII or FIX) between the ages of 5 and 18 years. Physical activity participation among different levels of disease severity will be compared using accelerometers to calculate the amount of time spent in moderate to vigorous physical activity (MVPA) and the number of bouts of MVPA; additionally, data will be collected from two validated questionnaires (PedHAL and 3 day physical activity recall). Current literature that relates level of physical activity to disease severity in the pediatric hemophilia population is limited. The information gained about the type and quantity of physical activity participation in children with varying levels of hemophilia will assist in the development of education and interventions to promote good physical activity and potentially examine the role of tailored prophylaxis.

Conditions

  • Hemophilia A
  • Hemophilia B
  • Factor VIII Deficiency
  • Factor IX Deficiency

Interventions

DEVICE

Accelerometer

Sponsors & Collaborators

  • Canadian Hemophilia Society

    collaborator OTHER

  • The Hospital for Sick Children

    lead OTHER

Principal Investigators

  • Vanessa Bouskill, NP, MN · The Hospital for Sick Children

Eligibility

Min Age
5 Years
Max Age
17 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-09-30
Primary Completion
2014-07-31
Completion
2016-09-30

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02199717 on ClinicalTrials.gov